Published: May 18, 2026

Listen: Navigating Immunotherapy Options for Allergic Rhinitis

Immunotherapy approaches can modify disease progression beyond symptom management, with individualized treatment plans for patients with allergic rhinitis.


AAO-HNS


Shutterstock 2578330645With allergy season well underway, we are re-sharing one of our popular Voices of Otolaryngology podcasts, “Navigating Immunotherapy Options for Allergic Rhinitis: SCIT vs. SLIT.

In this podcast, which was produced on behalf of the AAO-HNS Allergy, Asthma and Immunology Committee, Cecelia Damask, DO, and Matthew W. Ryan, MD, discuss the critical differences between subcutaneous and sublingual immunotherapy for allergic rhinitis treatment. Their in-depth discussion covers efficacy comparisons, safety profiles, cost considerations, and practical factors affecting patient adherence.

Allergen immunotherapy (AIT), which is a treatment used to reduce allergy symptoms and improve quality of life, has been shown to be safe and effective for treating allergic rhinitis. For allergens that are inhaled, AIT is usually administered using one of two methods:

  • Subcutaneous immunotherapy (SCIT)
  • Sublingual immunotherapy (SLIT)

Listen today!

Voices of Otolaryngology: Navigating Immunotherapy Options for Allergic Rhinitis: SCIT vs. SLIT

Additional Resources for You and Your Patients
Clinical Practice Guideline: Immunotherapy for Inhalant Allergy
ENThealth.org Treatment Options for Allergen Immunotherapy
ENThealth.org FAQs about Allergen Immunotherapy

 


More from May 2026 – Vol. 45, No. 5